Monica Donghi
Max Planck Society(DE)Max Planck Institute for Innovation and Competition(DE)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Synthetic Organic Chemistry Methods, Quinazolinone synthesis and applications, Synthesis and Reactivity of Heterocycles, Hepatitis C virus research
Most-Cited Works
- → Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection(2008)627 cited
- → A Combinatorial Approach to Polyketide-Type Libraries by Iterative Asymmetric Aldol Reactions Performed on Solid Support(2000)74 cited
- → Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection(2009)54 cited
- → Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors(2008)52 cited
- → Taxol Semisynthesis: A Highly Enantio- and Diastereoselective Synthesis of the Side Chain and a New Method for Ester Formation at C-13 Using Thioesters(1997)37 cited
- → Synthesis and evaluation of novel phosphoramidate prodrugs of 2′-methyl cytidine as inhibitors of hepatitis c virus NS5B polymerase(2009)34 cited
- → Stereocontrolled synthesis of polyketide libraries: Boron-mediated aldol reactions with aldehydes on solid support(1998)33 cited
- → Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: Structure-based design and synthesis of new templates(2010)30 cited
- → 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates—A new class of HIV-1 integrase inhibitors(2009)26 cited